Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Troubleshooting Implanted Ports

As a health care provider in the home setting, coming across various types of venous access devices is expected. Access devices can vary from peripherally inserted catheters for short-term or intermittently administered therapies, such as IVIG or infliximab, to centrally placed devices for long-term use, especially if there are venous access problems. A physician and patient should discuss and decide on the most appropriate venous access device while considering the duration of therapy, lifestyle, and history of venous access issues. Nurses are expected to maintain various types of central venous access devices (CVADs), such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs) such as Hickman™ and Broviac™ catheters, and implanted ports. Patients may already have a CVAD when admitted for home infusion therapy services or require placement after admission if they have poor or inaccessible venous access and the need for long-term therapy. This blog will focus on handling and troubleshooting ports. [More]

Infliximab, Biologics: Infusion Precautions

Biologics products have been developed to treat undesirable immune responses caused by chronic systemic inflammatory conditions. The immune system consists of a vast network of cells, tissues and organs that all perform specific functions to help keep the “host” in a state of equilibrium. Infliximab is a monoclonal antibody tumor necrosis factor α (TNF) inhibitor. That has been used to slow the progression of several inflammatory conditions, such as rheumatoid arthritis by blocking the activation of TNF, target specific therapy. [More]

Managing IVIG-Related Side Effects

Intravenous Immune Globulin (IVIG) infusions are generally well tolerated. Most associated side effects are mild and managed with multiple approaches which may include pre-medication, clinical consultation providing education on what to expect with infusion, ongoing monitoring of infusions, and modifications to the individualized patient infusion protocol if side effects occur. [More]

Management of SCIG Side effects

The greatest advantage of subcutaneous immunoglobulin (SCIG) is that it provides the patient with autonomy, which helps them feel empowered to live a normal life. Nurses are responsible for teaching patients how to manage the expected side effects. Most patients do not require premeds; if they are ordered, advise your patient to be compliant with them. Always ensure the anaphylaxis kit is readily available for each infusion regardless of past tolerability. It should consist of a double pack epinephrine autoinjector and oral Benadryl. Please instruct the patient how to use it properly before leaving their home. [More]